Contribution: Industrial Research Assistance Program – Contributions to Firms
MicroSintesis Inc.
$238,293.00
Potency Assay Development
FY 2023-24 · 2023-05-01
Summary
MicroSintesis is developing a Bioassay Platform that will be used to determine the potency of current and future products, and to validate the anti-virulence mode of action of candidate products against target pathogens of commercial interest. The collection of analytical and biological assays for the Bioassay Platform will monitor:
1) Virulence and Quorum Sensing Gene Expression changes, in selected pathogens, to the presence of the technology
2) Phenotypic behavioural response of selected pathogen to virulence gene changes
3) In vivo Clinical response to pathogen behaviour changes due to quorum inhibition
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Montreal|Montréal, Quebec, Canada
Recipient Type
For-profit organization
Business Number
843481516
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2023-05-01 | 2023-24 | $238,293.00 |
| 1 | 2023-05-01 | 2023-24 | $238,293.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 91 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 91 jours.
Agreement End Date
2024-03-31
Agreement Number
1007347
Agreement Start Date
2023-05-01
Agreement Title
Potency Assay Development
Agreement Title (French)
Développement d’un essai de puissance
Agreement Type
Contribution
Agreement Value
$238,293.00
Amendment Date
2024-02-06
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
MicroSintesis is developing a Bioassay Platform that will be used to determine the potency of current and future products, and to validate the anti-virulence mode of action of candidate products against target pathogens of commercial interest. The collection of analytical and biological assays for the Bioassay Platform will monitor:
1) Virulence and Quorum Sensing Gene Expression changes, in selected pathogens, to the presence of the technology
2) Phenotypic behavioural response of selected pathogen to virulence gene changes
3) In vivo Clinical response to pathogen behaviour changes due to quorum inhibition
Description (French)
MicroSintesis développe une plateforme d’essais biologiques qui sera utilisée pour déterminer la puissance des produits actuels et futurs, et pour valider le mode d’action anti-virulence des produits candidats contre des pathogènes cibles d’intérêt commercial. L’ensemble des essais analytiques et biologiques de la plateforme d’essais biologiques permettra de contrôler : 1) les modifications de l’expression des gènes de virulence et de détection du quorum, chez des agents pathogènes sélectionnés, en présence de la technologie ; 2) la réponse comportementale phénotypique de l’agent pathogène sélectionné aux modifications des gènes de virulence ; 3) la réponse clinique in vivo aux modifications du comportement de l’agent pathogène dues à l’inhibition du quorum.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Notre-Dame-de-Grâce--Westmount
Federal Riding (French)
Notre-Dame-de-Grâce--Westmount
Federal Riding Number
24053
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
843481516
Recipient City
Montreal|Montréal
Recipient Country
CA
Recipient Legal Name
MicroSintesis Inc.
Recipient Operating Name
MicroSintesis Inc.
Recipient Postal Code
H4A 3M8
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2023-2024-Q2-1007347
